ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

18,94
-0,47
(-2,42%)
Fermé 07 Mars 10:00PM
19,05
0,11
(0,58%)
Après les heures de négociation: 1:55AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
19,05
Prix Achat
17,01
Prix Vente
19,40
Volume échangé
1 120 008
18,63 Fourchette du Jour 19,43
5,12 Plage de 52 semaines 25,29
Cap du marché
Clôture Veille
19,41
Ouverture
18,87
Dernière Transaction
100
@
19.05
(formt)
Dernière heure de transaction
Volume financier
US$ 21 392 978
VWAP
19,1007
Volume moyen (3 m)
1 556 544
Actions en circulation
88 739 826
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,23
Bénéfice par action (BPA)
-3,62
Chiffre d'affairess
233,18M
Bénéfice net
-321,55M

À propos de Travere Therapeutics Inc

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Lewes, Delaware, USA
Fondé
-
Travere Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker TVTX. Le dernier cours de clôture d'Travere Therapeutics était de US$19,41. Au cours de la dernière année, les actions de Travere Therapeutics ont été négociées dans une fourchette de prix de US$ 5,12 à US$ 25,29.

Travere Therapeutics compte actuellement 88 739 826 actions en circulation. La capitalisation boursière d'Travere Therapeutics est de US$1,72 milliard. Travere Therapeutics a un ratio cours/bénéfice (ratio PE) de -5.23.

Flux d'options Travere Therapeutics (TVTX)

Flux global

Haussier

Prime nette

57k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

0,00%

Sweeps Ratio

0,00%

TVTX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.04-9.6728307254621.0921.9818.84155797920.22746708CS
4-2.29-10.731021555821.3425.2918.84211079622.03316116CS
120.4252.2818791946318.62525.2916.588155654420.23710899CS
268.0573.18181818181125.2910.8127172593317.72764654CS
5210.82131.4702308638.2325.295.12142748013.63948823CS
156-6.91-26.617873651825.9630.355.12126849115.4265548CS
260-6.1-24.25447316125.1533.08995.12110341016.83445622CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is US$ 19,05
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 88 739 826 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1,72B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of US$ 5,12 to US$ 25,29 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -5,23
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 7,21
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 233,18M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -321,55M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PSTVPlus Therapeutics Inc
US$ 1,46
(317,14%)
357,55M
AGMHAGM Group Holdings Inc
US$ 0,213
(108,21%)
690,72M
LZMHLZ Technology Holdings Ltd
US$ 9,79
(33,56%)
576,65k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 14,62
(33,39%)
15,92M
GVVisionary Holdings Inc
US$ 4,89
(32,34%)
134,05M
BLNEEastside Distilling Inc
US$ 0,7846
(-89,40%)
12,25k
ACONAclarion Inc
US$ 1,5501
(-77,86%)
51,53M
ELABPMGC Holdings Inc
US$ 0,7132
(-42,02%)
1,51M
SNBRSleep Number Corporation
US$ 7,49
(-41,89%)
4,56M
CCLDCareCloud Inc
US$ 2,0904
(-33,00%)
1,23M
AGMHAGM Group Holdings Inc
US$ 0,213
(108,21%)
694,71M
PSTVPlus Therapeutics Inc
US$ 1,46
(317,14%)
359,59M
NVDANVIDIA Corporation
US$ 110,57
(-5,74%)
321,25M
GVVisionary Holdings Inc
US$ 4,89
(32,34%)
135,24M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,75
(-11,38%)
134,95M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock